Bleakley Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Buy |
67,150
+534
| +0.8% | +$99.1K | 0.32% | 60 |
|
|
2025
Q1 | $14M | Buy |
66,616
+6,934
| +12% | +$1.45M | 0.45% | 43 |
|
|
2024
Q4 | $10.6M | Buy |
59,682
+9,879
| +20% | +$1.76M | 0.32% | 54 |
|
|
2024
Q3 | $9.84M | Sell |
49,803
-70,514
| -59% | -$13.9M | 0.3% | 53 |
|
|
2024
Q2 | $20.6M | Buy |
120,317
+2,776
| +2% | +$476K | 0.6% | 27 |
|
|
2024
Q1 | $21.4M | Buy |
117,541
+6,158
| +6% | +$1.12M | 0.62% | 25 |
|
|
2023
Q4 | $17.3M | Sell |
111,383
-549
| -0.5% | -$85.1K | 0.55% | 33 |
|
|
2023
Q3 | $16.7M | Buy |
111,932
+11,355
| +11% | +$1.69M | 0.59% | 33 |
|
|
2023
Q2 | $13.6M | Buy |
100,577
+13,167
| +15% | +$1.77M | 0.42% | 46 |
|
|
2023
Q1 | $13.9M | Sell |
87,410
-25,945
| -23% | -$4.13M | 0.47% | 38 |
|
|
2022
Q4 | $18.3M | Buy |
+113,355
| New | +$18.3M | 0.66% | 27 |
|